Severe acute respiratory syndrome

Connecticut Medicine

Volumn 68, Issue 4, 2004, Pages 207-215

  Aronin, Steven I ^a,b,c   Sadigh, Majid ^a,c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WATERBURY HOSPITAL   (United States)

^c Department of Medicine ^*  (United States)

^d ST MARY S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CORTICOSTEROID; RIBAVIRIN;

BODY FLUID; CHINA; CLINICAL FEATURE; ELECTROLYTE DISTURBANCE; EPIDEMIC; HEMOLYTIC ANEMIA; HISTOPATHOLOGY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY TEST; OPPORTUNISTIC INFECTION; RESPIRATORY TRACT DISEASE; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; THORAX RADIOGRAPHY; TRAVEL; VIRUS CLASSIFICATION;

EID: 2942623974     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. WHO, WER 7/2003: Acute respiratory syndrome, China. Wkly Epidemiol Rec 2003; 78:41.
2. WHO, WER 9/2003: Acute respiratory syndrome, China - Update. Wkly Epidemiol Rec 2003; 78:57.
3. CDC: Update: Outbreak of severe acute respiratory syndrome-worldwide, 2003. MMWR 2003; 52:241.
4. Reilley B, Van Herp M, Sermand D, Dentico N: SARS and Carlo Urbani. N Engl J Med 2003; 348:1951-2.
5. WHO, WER 18/2003: Vietnam SARS-free. Wkly Epidemiol Rec 2003; 78:145.
6. WHO, WER 11/2003: Acute respiratory syndrome-China, Hong Kong Special Administrative Region of China, and Viet Nam. Wkly Epidemiol Rec 2003; 78:73.
7. CDC: Severe acute respiratory syndrome-Singapore, 2003. MMWR 2003; 52:405.
8. Poutanen SM, Low DE, Henry B, et al: Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; 348:1995.
9. http://www.who.int/csr/sarsarchive/2003_03_15/en/
10. http://www.who.int/csr/sars/project/en/
11. Hong T, Wang, JW, Sun YL, et al: Chlamydia-like and coronavirus-like agents found in cases of atypical pneumonia by electron microscopy. Nat Med J China 2003; 83:632-6.
12. http://www.cdc.gov/od/oc/media/pressrel/r030324.htm
13. WHO Multicentre Collaborative Network for Severe Acute Respiratory Syndrome (SARS) Diagnosis: A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003; 361:1730-33.
14. Peiris JSM, Lai ST, Poon LLM, et al: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319.
15. Drosten C, Gunther S, Preiser W, et al: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967.
16. Ksiazek TG, Erdman D, Goldsmith CS, et al: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348:1953.
17. Fouchier RAM, Kuiken T, Schutten M, et al: Koch's postulates fulfilled for SARS virus. Nature 2003; 423:240.
18. Marra MA, Jones SJM, Astell CR, et al: The genome sequence of the SARS-associated coronavirus. Science 2003; 300:1399.
19. Rota PA, Oberste MS, Monroe SS, et al: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300:1394.
20. http://www.who.int/csr/sars/country/2003_08_15/en/
21. http://www.who.int/csr/sars/casedefinition/en/
22. http://www.cdc.gov/ncidod/sars/casedefinition.htm
23. Enserink M: Calling all coronavirologists. Science 2003; 300:413.
24. Lai MMC, Holmes KV: Coronoviridae and their replication. In Fields' Virology. Knipe DM, Howley PM Griffin DE, et al: Ed: Lippincott Williams & Wilkens. Philadelphia, USA. 2001; 1163-85.
25. Holmes KV: SARS coronavirus: A new challenge for prevention and therapy. J Clin Invest 2003; 111: 1605.
26. Holmes KV: Coronaviruses. In Fields' Virology. Knipe DM, Howley PM Griffin DE, et al: Ed: Lippincott Williams & Wilkens. Philadelphia, USA. 2001; 1187-203.
27. Sizun J, Yu MW, Talbot PJ: Survival of human coronaviruses 229E and OC43 in suspension after drying on surfaces: A possible source of hospital-acquired infections. J Hosp Infect 2000; 46:55.
28. Ijaz MK, Brunner AH, Sattar SA, et al: Survival characteristics of airborne human coronavirus 229E. J Gen Virol 1985; 66:2743.
29. He JF, Xu RH, Yu DW, et al: Severe acute respiratory syndrome in Guangdong Province of China: Epidemiology and control measures. Chin J Prev Med 2003; 37:227-32.
30. Guan Y, Zheng BJ, He YQ, et al: Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003; 302:276-8.
31. CDC: Prevalence of IgG antibody to SARS-associated coronavirus in animal handlers-Guangdong Province, China, 2003. MMWR 2003; 52:986-7.
32. Seto WH, Tsang D, Yung RWH, et al: Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361: 1519.
33. Peiris JS, Chu CM, Cheng VC, et al: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet 2003; 361:1767.
34. http://www.who.int/csr/sars/survival_2003_05_04/en/index.html
35. Chan PKS, Tam JS, Lam CW, et al: Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003; 9:1058-63.
36. Hsueh PR, Hsiao CH, Yeh SH, et al: Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003; 9:1163-7.
37. Li G, Zhao Z, Chen L, Zhou Y: Mild severe acute respiratory syndrome. Emerg Infect Dis 2003; 9:1182-3
38. Booth CM, Matukas LM, Tomlinson GA, et a:. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801.
39. Lee N, Hui D, Wu A, et al: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1986.
40. Sampathkumar P, Temesgen Z, Smith TF, Thompson RL: SARS: Epidemiology, clinical presentation, management, and infection control measures. Mayo Clin Proc 2003; 78:882.
41. WHO Update 49: SARS case fatality ratio, incubation period. May 7, 2003. http://www.who.int/csr/sarsarchive/2003_05_07a/en/
42. Hon KLE, Leung CW, Cheng WTF, et al: Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003; 361:1701-3.
43. Tsui PT, Kwok ML, Yuen H, Lai ST: Severe acute respiratory syndrome: Clinical outcome and prognostic correlates. Emerg Infect Dis 2003; 9:1064-9.
44. Fisher DA, Lim TK, Lim YT, et al: Atypical presentations of SARS. Lancet 2003; 361:1740.
45. Riley S, Fraser C, Donnelly CA, et al: Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science 2003; 300:1961-6.
46. CDC: Severe acute respiratory syndrome - Taiwan, 2003. MMWR 2003; 52:461-6.
47. Whitley RJ: Varicella-zoster infections. In: Antiviral Agents and Viral Infections of Man. Galasso G, Merigan T, Buchanan R, eds. New York: Raven Press: 1984:517-41.
48. Klimon AI, Rocha E, Hayden FG, et al: Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: Detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172:1352-5.
49. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165:987-93.
50. Wong RSM, Wu A, To KF, et al: Haematological manifestations in patients with severe acute respiratory syndrome: Retrospective analysis. BMJ 2003; 326:1358.
51. Wong KT, Antonio GE, Jui D, et al: Severe acute respiratory syndrome: Radiographic appearances and pattern of progression in 138 patients. Radiology 2003; 228:401-6.
52. Tsang KW, Ho PL, Ooi GC, et al: A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1977.
53. Nicholls JM, Poon LLM, Lee KC, et al: Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361:1773.
54. Fisman DN: Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6:60-8.
55. Mazzulli T, Farcas GA, Poutanen SM, et al: Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004; 10:
56. www.cdc.gov/ncidod/sars/absenceofsars.htm
57. www.cdc.gov/ncidod/sars/diagnosis.htm
58. http://www.moh.gov.sg/sars/pdf/Report_SARS_Biosafety.pdf
59. http://203.65.72.83/En/dia/ShowPublication.ASP?RecNo=938
60. Li G, Chen X, Xu A: Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med 2003; 349:508-9.
61. CDC: Guidelines for collection of specimens from potential cases of SARS. http://www.cdc.gov/ncidod/sars/specimen_collection_sars2.htm
62. Hsu L, Lee C, Green JA, et al: Severe acute respiratory syndrome (SARS) in Singapore: Clinical features of index patient and initial contacts. Emerg Infect Dis 2003; 9:713.
63. Fowler RA, Lapinsky SE, Hallett D, et al: Critically ill patients with severe acute respiratory syndrome. JAMA 2002; 290:367.
64. Lew TWK, Kwek T, Tai D, et al: Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003; 290:374.
65. So LK, Lau ACW, Yam LYC, et al: Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003; 361:1615.
66. Wang H, Ding Y, Li X, et al: Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N Engl J Med 2003; 349:507-8.
67. Cinatl J, Morgenstern B, Bauer G, et al; Treatment of SARS with human interferons. Lancet 2003; 362:293.
68. Loutfy MR, Blatt LM, Siminovitch KA, et al: Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome. A preliminary study. JAMA 2003; 290:3222-8.
69. CDC: Updated interim domestic infection control guidance in the health-care and community setting for patients with suspected SARS. http://www.cdc.gov/ncidod/sars/infectioncontrol.htm
70. Gao W, Tamin A, Soloff A, et al: Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003; 362:1895-6.
71. Shooter RA: Report of the investigation into the cause of the 1978 Birmingham smallpox occurrence. London, Her Majesty's Stationery Office, 1980.
72. Deria A, Jezek Z, Markavart K, et al: The world's last endemic case of smallpox. Bull WHO 1980; 58:279-83.
73. www.wpro.who.int/sars/docs/pressreleases/pr_04012004.asp
74. www.who.int/csr/don/2004_01_08/en/
75. McDade JE, Shepard CC, Fraser DW, et al: Legionnaires' disease. Isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977; 297:1197-203.
76. Grayston JT, Kuo CC, Wang SP, et al: Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315:161-8.
77. CDC: Outbreak of acute illness-southwestern United States, 1993. MMWR 1993; 42:421-4.